Pacira BioSciences, Inc. logo PCRX - Pacira BioSciences, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 15
HOLD 17
SELL 4
STRONG
SELL
0
| PRICE TARGET: $29.50 DETAILS
HIGH: $32.00
LOW: $27.00
MEDIAN: $29.50
CONSENSUS: $29.50
UPSIDE: 26.34%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

C- 44.8 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — no stock price or analyst input.

Profitability

Weight: 25%
F 14.1
  • 5yr Avg ROIC 2.0% 20/100
  • Operating Margin Trend -4.35 pp/yr 0/100
Contributes 3.5 pts toward composite.

Capital Efficiency

Weight: 15%
D- 31.6
  • 5yr Avg ROE 0.2% 11/100
  • 5yr Share-Count CAGR -0.3% 70/100
Contributes 4.7 pts toward composite.

Growth Quality

Weight: 25%
C 52.9
  • 5yr Revenue CAGR 7.6% 73/100
  • 5yr EPS CAGR -35.4% 0/100
  • Revenue-Growth Years (5) 5/5 100/100
Contributes 13.2 pts toward composite.

Cash Generation

Weight: 20%
B+ 78.2
  • 5yr FCF Margin 19.4% 89/100
  • 5yr FCF/NI Conversion 7.97x 65/100
Contributes 15.6 pts toward composite.

Balance Sheet

Weight: 10%
C 51.5
  • Net Debt / EBITDA 1.76x 74/100
  • Interest Coverage (EBIT/Int) 2.16x 31/100
  • Altman Z-Score 1.85 37/100
Contributes 5.2 pts toward composite.

Stability

Weight: 5%
C 51.7
  • EPS Volatility (σ/μ) 1.29 0/100
  • Piotroski F-Score 8 89/100
  • Negative-Revenue Years (5) 0/5 100/100
Contributes 2.6 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 added; 1 trimmed.

Holders
2
Avg Δ position
+16.8%
New buys
0
Full exits
0
As of Q1 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Piotroski F-Score, Negative-Revenue Years (5)

We deliberately ignore stock price, analyst targets, and consensus ratings so the grade is suitable for backtesting forward returns. A minimum of 5 fiscal years of audited statements is required; distressed and highly leveraged infrastructure businesses are declared ungradable rather than forced into a numeric score.